Innoviva (INVA) Acquisitions (2022)
Innoviva's (INVA) quarterly Acquisitions came in at $23.1 million in Q3 2022, little changed on a QoQ basis from $23.1 million in Q1 2022.
Innoviva (INVA) Acquisitions (2022) Analysis & Trends
Innoviva (INVA) has 1 years of Acquisitions data on file, last reported at $23.1 million in Q3 2022.
- Quarterly Acquisitions changed N/A year-over-year to $23.1 million in Q3 2022, while the trailing twelve-month figure through Sep 2023 was $23.1 million (down 50.0% YoY) and the FY2022 annual result came in at $23.1 million, changed N/A from the prior year.
- Acquisitions steadied at $23.1 million in Q3 2022, from $23.1 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $23.1 million in Q1 2022 to a low of $23.1 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 23.07 Mn |
| Mar 31, 2022 | 23.07 Mn |